Browse the corpus

REFERENCES Center for Substance Abuse Treatment, Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction , Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04���3939. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004 “Drugs for Pain,” Med Lett Drugs Ther , 2000, 42(1085):73-8. [PubMed 10951654 ] Gal TJ, “Naloxone Reversal of Buprenorphine-Induced Respiratory Depression,” Clin Pharmacol Ther , 1989, 45(1):66-71. [PubMed 2491980 ] Harcus AH, Ward AE, and Smith DW, “Buprenorphine: Experience in an Elderly Population of 975 Patients During a Year's Monitored Release,” Br J Clin Pract , 1980, 34(5):144-6. [PubMed 7407029 ] Jain PN and Shah SC, “Respiratory Depression Following Combination of Epidural Buprenorphine and Intramuscular Ketorolac,” Anaesthesia , 1993, 48(10):898-9. [PubMed 8238835 ] Kuhlman JJ Jr, Lalani S, Magluilo J Jr, et al, “Human Pharmacokinetics of Intravenous, Sublingual and Buccal Buprenorphine,” J Anal Toxicol , 1996, 20(6):369-78. [PubMed 8889672 ] MacEvilly M and O'Carroll C, “Hallucinations After Epidural Buprenorphine,” Br Med J , 1989, 298(6678):928-9. Mokhlesi B, Leikin JB, Murray P, et al, “Adult Toxicology in Critical Care: Part II: Specific Poisonings,” Chest , 2003, 123(3):897-922. [PubMed 12628894 ] “Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,” 6th ed, Glenview, IL: American Pain Society, 2008. Sporer KA, “Buprenorphine: A Primer for Emergency Physicians,” Ann Emerg Med , 2004, 43(5):580-4. [PubMed 15111917 ] Welsh CJ, Suman M, Cohen A, et al, “The Use of Intravenous Buprenorphine for the Treatment of Opioid Withdrawal in Medically Ill Hospitalized Patients,” Am J Addict , 2002, 11(2): 135-40. [PubMed 12028743 ] Topic 9170 Version 49.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [0504-190.92.87.104-A2ED1F3088-S473950.14]